E-LIB Suche - Ergebnisse für: Wientjes, Maike

1

Prediction of response to anti-TNF treatment using laborato..:

Wientjes, Maike H M ; den Broeder, Alfons A ; Welsing, Paco M J..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730399/. , 2022

Link: http://www.ncbi.nlm.nih...

2

Using adalimumab serum concentration to choose a subsequent..:

Wientjes, Maike H. M ; Atiqi, Sadaf ; Wolbink, Gerrit Jan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214249/. , 2021

Link: http://www.ncbi.nlm.nih...

3

Risk factors for in-hospital mortality in laboratory-confir..:

Gerine Nijman ; Maike Wientjes ; Jordache Ramjith...
https://doi.org/10.1371/journal.pone.0249231. , 2021

Link: https://doi.org/10.1371/..

4

Anonymized dataset:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/dataset/Anonymized_dataset_/14324015. , 2021

Link: https://doi.org/10.1371/..

5

Characteristics of the study population:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/dataset/Characteristics_of_the_study_population_/14324027. , 2021

Link: https://doi.org/10.1371/..

6

Cumulative incidence plot of death and recovery in the tota..:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/figure/Cumulative_incidence_plot_of_death_and_recovery_in_the_total_population_/14324018. , 2021

Link: https://doi.org/10.1371/..

7

Univariable and multivariable cause-specific hazard ratios ..:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/dataset/Univariable_and_multivariable_cause-specific_hazard_ratios_HR_sub_CS_sub_including_95_confidence_intervals_for_death_and_recovery_/14324030. , 2021

Link: https://doi.org/10.1371/..

8

Flowchart of inclusion:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/journal_contribution/Flowchart_of_inclusion_/14324009. , 2021

Link: https://doi.org/10.1371/..

9

STROBE statement—checklist of items that should be included..:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/journal_contribution/STROBE_statement_checklist_of_items_that_should_be_included_in_reports_of_i_cohort_studies_i_/14324006. , 2021

Link: https://doi.org/10.1371/..

10

Cumulative incidence plot of death and recovery in the tota..:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/figure/Cumulative_incidence_plot_of_death_and_recovery_in_the_total_population_separated_by_age_group_/14324021. , 2021

Link: https://doi.org/10.1371/..

11

Cumulative incidence plot of death and recovery in the tota..:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/figure/Cumulative_incidence_plot_of_death_and_recovery_in_the_total_population_separated_by_sex_/14324024. , 2021

Link: https://doi.org/10.1371/..

12

Schoenfeld residuals plots:

Gerine Nijman (10475150) ; Maike Wientjes (10475153) ; Jordache Ramjith (8849438)...
https://figshare.com/articles/journal_contribution/Schoenfeld_residuals_plots_/14324012. , 2021

Link: https://doi.org/10.1371/..

13

Prediction of response to anti-TNF treatment using laborato..:

Alfons A den Broeder ; Paco M J Welsing ; Bart J F van den Bemt..
https://rmdopen.bmj.com/content/8/2/e002570.full. , 2022

Link: https://doi.org/10.1136/..

14

Using adalimumab serum concentration to choose a subsequent..:

Maike H. M. Wientjes ; Sadaf Atiqi ; Gerrit Jan Wolbink...
https://doi.org/10.1186/s13063-021-05358-7. , 2021

Link: https://doi.org/10.1186/..

15

Additional file 1 of Using adalimumab serum concentration t..:

Maike H. M. Wientjes (10996986) ; Sadaf Atiqi (10996989) ; Gerrit Jan Wolbink (10996992)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Using_adalimumab_serum_concentration_to_choose_a_subsequent_biological_DMARD_in_rheumatoid_arthritis_patients_failing_adalimumab_treatment_ADDORA-switch_study_protocol_for_a_fully_blinded_randomised_superiority_test-tre/14812440. , 2021

Link: https://doi.org/10.6084/..